Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?

Journal of Experimental Medicine

Volumn 189, Issue 5, 1999, Pages 865-870

  Kerschensteiner, Martin ^a   Gallmeier, Eike ^a   Behrens, Lüder ^a   Leal, Vivian Vargas ^a   Misgeld, Thomas ^a   Klinkert, Wolfgang E F ^a   Kolbeck, Roland ^a   Hoppe, Edmund ^a   Oropeza Wekerle, Rosa Laura ^b   Bartke, Ilse ^c   Stadelmann, Christine ^d   Lassmann, Hans ^d   Wekerle, Hartmut ^a   Hohlfeld, Reinhard ^a,e  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoimmunity; Immunosuppressive therapy; Multiple sclerosis; Neurodegeneration; Neurotrophic factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MYELIN BASIC PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL SURVIVAL; ENCEPHALITIS; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INFLAMMATORY INFILTRATE; MOTONEURON; NERVE DEGENERATION; NEUROPROTECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033103608     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.5.865     Document Type: Article

References (25)

1. Leibrock, J., F. Lottspeich, A. Hohn, M. Hofer, B. Hengerer, P. Masiakowski, H. Thoenen, and Y.-A. Barde. 1989. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:149-152.
2. Lewin, G.R., and Y.-A. Barde. 1996. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:289-317.
3. Hofer, M., S.R. Pagliusi, A. Hohn, A. Leibrock, and Y.-A. Barde. 1990. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO (Eur. Mol. Biol. Organ.) J. 9:2459-2464.
4. Klein, R., V. Nanduri, S. Jing, F. Lamballe, P. Tapley, S. Bryant, C. Cordon-Cardo, K.R. Jones, L.F. Reichardt, and M. Barbacid. 1991. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 66:395-403.
5. Lomen-Hoerth, C., and E.M. Shooter. 1995. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J. Neurochem. 64:1780-1789.
6. Sendtner, M., B. Holtmann, R. Kolbeck, H. Thoenen, and Y.-A. Barde. 1992. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature. 360:757-759.
7. Yan, Q., J. Elliott, and W.D. Snider. 1992. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature. 360:753-755.
8. Gravel, C., R. Götz, A. Lorrain, and M. Sendtner. 1997. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat. Med. 3:765-769.
9. Kobayashi, N.R., D.-P. Fan, K.M. Giehl, A.M. Bedard, S.J. Wiegand, and W. Tetzlaff. 1997. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Tα1-tubulin mRNA ex-pression, and promote axonal regeneration. J. Neurosci. 17: 9583-9595.
10. McTigue, D.M., P.J. Horner, B.T. Stokes, and F.H. Gage. 1998. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 18:5354-5365.
11. Mitsumoto, H., K. Ikeda, B. Klinkosz, J.M. Cedarbaum, V. Wong, and R.M. Lindsay. 1994. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science. 265:1107-1110.
12. Sagot, Y., R. Vejsada, and A.C. Kato. 1997. Clinical and molecular aspects of motoneurone diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein. Trends Pharmacol. Sci. 18:330-337.
13. Pette, M., K. Fujita, D. Wilkinson, D.M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J.T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA. 87:7968-7972.
14. Götz, R., R. Kolbeck, F. Lottspeich, and Y.-A. Barde. 1992. Production and characterization of recombinant mouse neurotrophin-3. Eur.J. Biochem. 204:745-749.
15. Vass, K., M.L. Berger, T.S. Nowak, W.J. Welch, and H. Lassmann. 1989. Induction of stress protein hsp70 in nerve cells after status epilepticus in the rat. Neurosci. Lett. 100: 259-264.
16. Barde, Y.-A. 1997. Help from within for damaged neurons. Nature. 385:391-392.
17. Thoenen, H. 1995. Neurotrophins and neuronal plasticity. Science. 270:593-598.
18. Kramer, R., Y. Zhang, J. Gehrmann, R. Gold, H. Thoenen, and H. Wekerle. 1995. Gene transfer through the blood-nerve barrier: nerve growth factor engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nat. Med. 1:1162-1166.
19. Rapalino, O., O. Lazarov-Spiegler, E. Agranov, G.J. Velan, E. Yoles, M. Fraidakis, A. Solomon, R. Gepstein, A. Katz, M. Belkin, et al. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4:814-821.
20. Neumann, H., T. Misgeld, K. Matsumuro, and H. Wekerle. 1998. Neurotrophins inhibit class II inducibility of microglia: involvement of the p75 receptor. Proc. Natl. Acad. Sci. USA. 95:5779-5784.
21. Torcia, M., L. Bracci-Laudiero, M. Lucibello, L. Nencioni, D. Labardi, A. Rubatelli, F. Cozzolino, L. Aloe, and E. Garaci. 1996. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell. 85:345-356.
22. Steinman, L. 1993. Connections between the immune system and the nervous system. Proc. Natl. Acad. Sci. USA. 90: 7912-7914.
23. Neumann, H., and H. Wekerle. 1998. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J. Neuropathol. Exp. Neurol. 58:1-9.
24. Cohen, I.R. 1992. The cognitive paradigm and the immunological homunculus. Immunol. Today. 13:490-494.
25. Hohlfeld, R. 1997. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain. 120:865-916.